Xiamen Amoytop Biotech Co Ltd Class A 688278
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥60.50
- Day Range
- ¥60.53–63.25
- 52-Week Range
- ¥37.73–69.97
- Bid/Ask
- ¥63.25 / ¥63.28
- Market Cap
- ¥25.73 Bil
- Volume/Avg
- 1.4 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 37.92
- Price/Sales
- 10.76
- Dividend Yield (Trailing)
- 0.65%
- Dividend Yield (Forward)
- 0.65%
- Total Yield
- 0.65%
Company Profile
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,960
- Website
- http://www.amoytop.com
Comparables
Valuation
|
Metric
|
688278
|
300122
|
301207
|
|---|---|---|---|
Price/Earnings (Normalized) | 37.92 | 11.23 | 15.59 |
Price/Book Value | 12.78 | 2.11 | 1.84 |
Price/Sales | 10.76 | 1.43 | 4.74 |
Price/Cash Flow | 34.36 | 9.26 | 11.51 |
Price/Earnings
688278
300122
301207
Financial Strength
|
Metric
|
688278
|
300122
|
301207
|
|---|---|---|---|
Quick Ratio | 3.14 | 1.37 | 2.85 |
Current Ratio | 4.07 | 2.07 | 3.42 |
Interest Coverage | 1,553.17 | 76.85 | 149.96 |
Quick Ratio
688278
300122
301207
Profitability
|
Metric
|
688278
|
300122
|
301207
|
|---|---|---|---|
Return on Assets (Normalized) | 30.63% | 11.64% | 9.24% |
Return on Equity (Normalized) | 37.49% | 19.62% | 11.52% |
Return on Invested Capital (Normalized) | 37.06% | 17.67% | 10.82% |
Return on Assets
688278
300122
301207
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Xrlvpbyqg | Zvrq | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Scdxhvxc | Xpqmkxd | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Lywtdws | Qpqklq | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Qjpfhmq | Mdxknsn | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Qdpzqlg | Kchc | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Vpyhjkbcs | Tbty | $28.1 Bil | |||
| Moderna Inc
MRNA
| Cscybnf | Tmbkx | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Dgjkclx | Xybl | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Bntspzq | Mgrjbbl | $13.4 Bil | |||
| Incyte Corp
INCY
| Xxsxpgnqk | Qxbzr | $12.7 Bil |
United States